HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Presence Of Contaminant In Bath Products Fuels Safe Cosmetics Campaign

This article was originally published in The Rose Sheet

Executive Summary

The presence of suspected carcinogen 1,4 dioxane in a number of personal care products is further evidence that tighter regulation is warranted, according to the Campaign for Safe Cosmetics

You may also be interested in...



Investors Call For Greater Safety Disclosure To Protect Cosmetics Market

On the heels of a push by activist groups to take beauty companies to task for suspected toxins in their products, the Investor Environmental Health Network (IEHN) asks that companies avoid market disruptions by eliminating harmful ingredients

Investors Call For Greater Safety Disclosure To Protect Cosmetics Market

On the heels of a push by activist groups to take beauty companies to task for suspected toxins in their products, the Investor Environmental Health Network (IEHN) asks that companies avoid market disruptions by eliminating harmful ingredients

California Cosmetics Bill Implementation Likely To Occur In Stages – CTFA

The California Department of Health Services likely will implement the California Safe Cosmetics Act in stages, and could decide to extend the Jan. 1 effective date altogether, according to CTFA Exec VP-Government Affairs John Hurson

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014545

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel